Influenza Division (CDC)

Influenza Division (CDC)
Agency name	Influenza Division (CDC)
Formed	1947
Jurisdiction	United States Department of Health and Human Services
Headquarters	Atlanta, Georgia
Parent agency	Centers for Disease Control and Prevention

Influenza Division (CDC) The Influenza Division (CDC) is a unit within the Centers for Disease Control and Prevention focused on influenza surveillance, vaccine strain selection, antiviral guidance, and pandemic preparedness. The Division coordinates with national and international institutions to monitor seasonal and novel influenza viruses, inform Food and Drug Administration vaccine licensure decisions, and support responses to outbreaks such as the 2009 flu pandemic and seasonal epidemics. Its activities intersect with agencies and organizations including the World Health Organization, National Institutes of Health, Pan American Health Organization, and academic centers.

Overview

The Influenza Division operates laboratories, epidemiology programs, and data analysis units that provide guidance to agencies like the Department of Health and Human Services, Veterans Health Administration, and state health departments such as the New York State Department of Health and California Department of Public Health. Its work informs recommendations issued by bodies including the Advisory Committee on Immunization Practices and supports interventions used by healthcare systems like the Mayo Clinic and Johns Hopkins Hospital. The Division collaborates with vaccine manufacturers including Moderna, Inc., GlaxoSmithKline, and Sanofi on strain selection and effectiveness studies, and works with laboratories such as the Walter Reed Army Institute of Research and the US Naval Medical Research Center.

History

The Division traces roots to post-World War II influenza investigations alongside institutions like the Rockefeller Foundation and the National Institutes of Health. It expanded during events including the 1957 influenza pandemic and 1968 influenza pandemic, and played a central role during the 2009 flu pandemic. The Division has contributed to vaccine strain selection processes in partnership with the World Health Organization and advisory mechanisms connected to the Advisory Committee on Immunization Practices and regulatory review by the Food and Drug Administration. Historical collaborations include work with the Centers for Disease Control and Prevention predecessors and academic partners such as Harvard Medical School and the University of Oxford.

Organization and Leadership

Organizational components include laboratory branches, epidemiology teams, vaccine effectiveness units, and modeling groups that coordinate with centers such as the National Center for Immunization and Respiratory Diseases and the Epidemic Intelligence Service. Leadership has included senior scientists and directors who liaise with figures at the Department of Health and Human Services and international counterparts at the World Health Organization. The Division’s structure supports links with research institutions like CDC Foundation, Emory University, and public health schools including the Johns Hopkins Bloomberg School of Public Health.

Programs and Activities

Core programs include seasonal influenza vaccination guidance, antiviral policy, risk communication, and pandemic preparedness planning used by agencies including Federal Emergency Management Agency and state emergency operations centers. Activities span vaccine strain selection in coordination with the World Health Organization Global Influenza Surveillance and Response System, antiviral effectiveness studies with partners such as University of Oxford and Imperial College London, and laboratory characterization in collaboration with the World Health Organization Collaborating Centres for Reference and Research on Influenza. The Division also administers training programs like the Epidemic Intelligence Service and supports immunization campaigns with partners such as UNICEF and Gavi, the Vaccine Alliance.

Surveillance and Research

Surveillance systems maintained by the Division feed data into global networks including the Global Influenza Surveillance and Response System and regional entities like the Pan American Health Organization. Research covers antigenic and genetic characterization, vaccine effectiveness studies with institutions such as Brown University and University of Michigan, and modeling efforts linked to groups at Imperial College London and the Institute for Health Metrics and Evaluation. Laboratory collaborations include work with the Centers for Disease Control and Prevention, the World Health Organization Collaborating Centre, and military research laboratories like Walter Reed Army Institute of Research.

Public Health Impact and Response

The Division informs public health responses to seasonal epidemics and pandemics, contributing to policy decisions used by bodies like the Advisory Committee on Immunization Practices and emergency responses coordinated with the Federal Emergency Management Agency and state health departments. Its outputs support clinical guidelines used by hospitals such as Mayo Clinic and Massachusetts General Hospital and influence vaccine programs implemented by entities including the Health Resources and Services Administration. The Division’s surveillance data underpin economic and burden assessments produced with partners like the Centers for Medicare & Medicaid Services and academic centers including University of Washington.

Partnerships and Global Collaboration

Key partners include the World Health Organization, Pan American Health Organization, national public health institutes such as the Public Health England (now UK Health Security Agency), and academic collaborators including Johns Hopkins University, Harvard University, and University of Oxford. The Division works with philanthropic and global health organizations like Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, and UNICEF to support vaccine access, and engages with regulatory agencies including the Food and Drug Administration and international counterparts such as the European Medicines Agency. Military and research collaborations include the Walter Reed Army Institute of Research and the Naval Medical Research Center.

Category:Centers for Disease Control and Prevention